The Latest
New Campaign, Toolkit Gets Providers PrEP'd for Women
New York City aims to expand PrEP and PEP access by educating more clinicians that serve women.
This Week in HIV Research: Better Serving the Underserved
May 9, 2019: HIV care retention and viral suppression among transgender women; heating opioid use equipment to curb HIV transmission; managing HIV outbreaks among people who are homeless; improving viral suppression among people who use substances.
This Week in HIV Research: Disparities Drive the Epidemic
April 25, 2019: stigma and viral load among African-American women; U.S. HIV incidence sans racial disparities; the care continuum is failing young MSM; a moment of reckoning regarding HIV among U.S. youth.
Overdoses and Smoking Are Taking the Lives of People With HIV Who Have Been Cured of Hepatitis C
"Providing HCV treatment alone while neglecting to concurrently address the social determinants of health will do little to improve the health outcomes of the majority of individuals with chronic HCV," the study authors wrote.
The Opioid Epidemic Is Fueling HIV Cluster Outbreaks -- Here's How the CDC is Responding
Epidemiologists are using a combination of molecular surveillance and tuberculosis-style contact tracing in hopes of helping local health departments curb HIV transmissions.
Many Providers Are Biased Against Prescribing PrEP to People Who Inject Drugs
Health care providers often believe stereotypes that PWID are irresponsible and won't adhere to PrEP, according to data presented at the 2019 National HIV Prevention Conference.
'Drug Users Are People Too': Addressing Opioid Addiction, Chemsex, Alcoholism, and Smoking Among People Living With HIV
A CROI 2019 symposium demonstrated the need for continued research and programs that address substance use and its impact on people living with HIV.
Drug Use May Be Increasing Syphilis Rates Among HIV-Positive Cisgender Women, Studies Show
The global increase in sexually transmitted infections was a major focus of the CROI 2019 meeting in Seattle, Washington.
Pharma Payments to Doctors Associated With Spike in Opioid Deaths, New Study Reveals
After years of anecdotes and speculation, harm reduction and pharma watchdog advocates have data to back claims that the spike in opioid deaths in the U.S. can be tied to pharmaceutical companies marketing highly addictive opioids to doctors.
This Week in HIV Research: This Is Your Brain on Stigma
The impact of stigma on cognitive performance; risk factor dissonance among young black MSM; pregnancy and the HIV care continuum; new data on pediatric raltegravir use.